CAMP Q3 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$96M+7.0% YoY

Gross Profit

$40M41.5% margin

Operating Income

$4M4.4% margin

Net Income

-$854,000-0.9% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$611M

Total Liabilities

$401M

Stockholders' Equity

$210M

Cash & Equivalents

$274M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$96M	$90M	+7.0%
Gross Profit	$40M	$37M	+8.1%
Operating Income	$4M	$3M	+35.7%
Net Income	-$854,000	$12M	-107.0%

Revenue Segments

Product

$77M80%

Application Subscriptions And Related Products And Other Services

$19M20%

Geographic Segments

UNITED STATES

$71M74%

E M E A

$14M14%

All Other

$4M4%

Asia Pacific

$3M4%

CANADA

$2M2%

South America

$2M2%